Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127238041 | 12723804 | 1 | I | 20160715 | 20160908 | 20160908 | EXP | IE-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-122521 | RANBAXY | 14.00 | YR | M | Y | 0.00000 | 20160908 | MD | IE | IE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127238041 | 12723804 | 1 | SS | MEROPENEM. | MEROPENEM | 1 | Intravenous (not otherwise specified) | 40 MG PER KG PER DOSE [TO A MAXIMUM OF 2 G PER DOSE] | Y | U | 0 | 40 | MG/KG | ||||||
| 127238041 | 12723804 | 2 | SS | TOBRAMYCIN. | TOBRAMYCIN | 1 | Unknown | 300 MG, BID | U | U | 0 | 300 | MG | Q12H | |||||
| 127238041 | 12723804 | 3 | SS | Colistin | COLISTIN | 1 | Unknown | TWO MEGA-UNITS TWICE DAILY | U | U | 0 | ||||||||
| 127238041 | 12723804 | 4 | SS | AZTREONAM. | AZTREONAM | 1 | Unknown | 75 MG, TID | U | U | 0 | 75 | MG | Q8H | |||||
| 127238041 | 12723804 | 5 | PS | AZITHROMYCIN ANHYDROUS. | AZITHROMYCIN ANHYDROUS | 1 | Oral | 250 MG, DAILY | U | U | 90923 | 250 | MG | ||||||
| 127238041 | 12723804 | 6 | C | CEFTAZIDIME. | CEFTAZIDIME | 1 | Intravenous (not otherwise specified) | 50 MG/KG, TID | U | U | 0 | 50 | MG/KG | Q8H | |||||
| 127238041 | 12723804 | 7 | C | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | Oral | 15 MG/KG, UNK | U | U | 0 | 15 | MG/KG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127238041 | 12723804 | 1 | Pseudomonas infection |
| 127238041 | 12723804 | 2 | Pseudomonas infection |
| 127238041 | 12723804 | 3 | Pseudomonas infection |
| 127238041 | 12723804 | 4 | Pseudomonas infection |
| 127238041 | 12723804 | 5 | Pseudomonas infection |
| 127238041 | 12723804 | 6 | Pseudomonas infection |
| 127238041 | 12723804 | 7 | Pseudomonas infection |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127238041 | 12723804 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127238041 | 12723804 | Back pain | |
| 127238041 | 12723804 | Drug resistance | |
| 127238041 | 12723804 | Myalgia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |